HK1216389A1 - 治療局部微生物感染的方法 - Google Patents

治療局部微生物感染的方法

Info

Publication number
HK1216389A1
HK1216389A1 HK16104321.4A HK16104321A HK1216389A1 HK 1216389 A1 HK1216389 A1 HK 1216389A1 HK 16104321 A HK16104321 A HK 16104321A HK 1216389 A1 HK1216389 A1 HK 1216389A1
Authority
HK
Hong Kong
Prior art keywords
methods
microbial infections
treating topical
topical microbial
treating
Prior art date
Application number
HK16104321.4A
Other languages
English (en)
Inventor
Stephen Page
Original Assignee
Luoda Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013900412A external-priority patent/AU2013900412A0/en
Application filed by Luoda Pharma Pty Ltd filed Critical Luoda Pharma Pty Ltd
Publication of HK1216389A1 publication Critical patent/HK1216389A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK16104321.4A 2013-02-08 2016-04-15 治療局部微生物感染的方法 HK1216389A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013900412A AU2013900412A0 (en) 2013-02-08 Methods Of Treating Microbial Infections, Including Skin Infections
PCT/AU2014/000101 WO2014121342A1 (en) 2013-02-08 2014-02-10 Methods of treating topical microbial infections

Publications (1)

Publication Number Publication Date
HK1216389A1 true HK1216389A1 (zh) 2016-11-11

Family

ID=51299090

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104321.4A HK1216389A1 (zh) 2013-02-08 2016-04-15 治療局部微生物感染的方法

Country Status (11)

Country Link
US (1) US9943500B2 (zh)
EP (1) EP2953623B1 (zh)
JP (1) JP2016507532A (zh)
KR (1) KR20150119007A (zh)
CN (3) CN111905104A (zh)
AU (1) AU2014214547B2 (zh)
CA (1) CA2900372C (zh)
HK (1) HK1216389A1 (zh)
MX (1) MX359921B (zh)
RU (1) RU2675360C2 (zh)
WO (1) WO2014121342A1 (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017003251A (es) 2014-09-12 2017-12-20 Antibiotx Aps Uso antibacteriano de salicilanilidas halogenadas.
TWI656872B (zh) * 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
CN105218562A (zh) * 2015-09-30 2016-01-06 浙江汇能动物药品有限公司 一种d(-)-磺苄西林钠的制备方法
EP3500254B1 (en) * 2016-08-16 2022-03-23 University of Rochester Pharmaceutical composition containing polymyxin b/trimethoprim based therapeutics
RU2763296C2 (ru) 2016-12-15 2021-12-28 Сосьете Де Продюи Нестле С.А. Композиции и способы, которые регулируют бактерии у животного-компаньона
CN106693924B (zh) * 2016-12-16 2019-06-11 昆明理工大学 一种纳米二氧化硅吸附剂、制备方法及其应用
CN106943349B (zh) * 2017-04-21 2020-12-11 华南农业大学 一种泰地罗新混悬注射液及其制备方法
IT201700060645A1 (it) * 2017-06-01 2018-12-01 Abiogen Pharma Spa Uso di xibornolo come agente attivo nel trattamento dell’acne volgare
CN108977481B (zh) * 2017-11-08 2021-08-27 北大方正集团有限公司 一种发酵生产麦白霉素的方法
CN108165511B (zh) * 2018-01-22 2020-11-20 四川农业大学 一种筛选培养基及制备方法和应用与微生物的筛选培养方法
CN108403676B (zh) 2018-03-20 2020-08-21 中山大学 琥珀酸在提高细菌对抗生素敏感性方面的应用
CN108663463A (zh) * 2018-08-16 2018-10-16 齐鲁动物保健品有限公司 一种泰地罗新的含量检测方法
US11318149B2 (en) * 2018-09-27 2022-05-03 Board Of Trustees Of Michigan State University Compositions and methods for inhibiting biofilm-forming bacteria
CN111195246A (zh) * 2018-11-16 2020-05-26 广西医科大学 聚醚类抗生素k-41b、k-41a在制备治疗或预防艾滋病毒药物中的应用
CN109452294B (zh) * 2018-12-05 2022-05-17 北京市农林科学院 一种防控瓜类细菌性果斑病的方法及其专用种子杀菌剂
WO2020123559A1 (en) * 2018-12-11 2020-06-18 Glyciome, Llc Topical, isotonic compositions for genital use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN109806273B (zh) * 2019-03-05 2021-07-02 艾美科健（中国）生物医药有限公司 泰拉霉素和加米霉素的复合溶液剂及其制备方法与应用
BR112021018863A2 (pt) * 2019-04-24 2021-11-30 Unilever Ip Holdings Bv Composição de cuidados pessoais, composição pessoal, método de preservação de composições e uso de uma combinação
CN110172524B (zh) * 2019-06-05 2021-06-11 华中农业大学 制定鸡产气荚膜梭菌对阿维拉霉素的耐药判定标准的方法
CN110128486B (zh) * 2019-06-19 2022-12-02 常州齐晖药业有限公司 一种泰拉霉素的合成方法
CN110372729B (zh) * 2019-08-06 2022-03-22 泊诺(天津)创新医药研究有限公司 一种氟氧头孢钠的精制方法
CN110865134A (zh) * 2019-10-22 2020-03-06 河北远征药业有限公司 一种泰地罗新含量检测方法
CN111150876B (zh) * 2020-01-06 2020-12-01 中国科学院长春应用化学研究所 耐药性可视化的创可贴及其制备方法
WO2021209025A1 (en) * 2020-04-17 2021-10-21 Shenzhen Pharmacin Co., Ltd Pharmaceutical compositions
CN113813283B (zh) * 2020-06-19 2023-12-12 中山大学附属第六医院 一类化合物促皮肤损伤修复的用途
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
CN113318107B (zh) * 2021-07-08 2022-07-12 中国科学院微生物研究所 一种含氮化合物在制备抗真菌药物中的应用
CN113712988A (zh) * 2021-08-17 2021-11-30 塔里木大学 一种槲皮素-替米考星聚合物纳米微粒、其制备方法及应用
CN113975373A (zh) * 2021-11-18 2022-01-28 宁波市眼科医院 眼用制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2171966B1 (zh) * 1972-02-17 1975-03-14 Pierrefitte Auby Sa
US3873693A (en) 1974-03-11 1975-03-25 Squibb & Sons Inc Ionomycin
US4772470A (en) * 1985-04-27 1988-09-20 Nitto Electric Industrial Co., Ltd. Oral bandage and oral preparations
BG45570A1 (en) 1987-06-11 1989-07-14 Stefan G Dundarov Means for virus desease cure
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US6187800B1 (en) * 1996-06-20 2001-02-13 Novartis Animal Health U.S., Inc. Method for the prevention and treatment of mastitis
US7223416B2 (en) * 1999-06-28 2007-05-29 Minu, L.L.C. Topical composition
CA2316767A1 (en) * 1999-09-01 2001-03-01 Bridget Mccarthy Cole Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
ATE318600T1 (de) * 1999-11-12 2006-03-15 Merck & Co Inc Diaryl piperidyl-pyrrol-derivate als antiprotozoenmittel
CN1646124B (zh) * 2002-04-22 2010-05-26 宝洁公司 具有锌离子载体性能的物质的使用
WO2006081327A2 (en) * 2005-01-25 2006-08-03 University Of Vermont And State Agricultural College Small molecules that reduce fungal growth
WO2008075207A2 (en) * 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
GB0709513D0 (en) * 2007-05-17 2007-06-27 Helperby Therapeutics Ltd Topical formulations
CN102427801A (zh) * 2009-04-13 2012-04-25 苏鲁·苏布拉马尼·瓦南加穆迪 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法
KR20190038679A (ko) * 2012-11-13 2019-04-08 난트 홀딩스 아이피, 엘엘씨 칼슘 유동 작동제 및 이의 방법

Also Published As

Publication number Publication date
AU2014214547A1 (en) 2015-08-20
EP2953623B1 (en) 2021-06-30
MX359921B (es) 2018-10-16
WO2014121342A1 (en) 2014-08-14
CN113144197A (zh) 2021-07-23
RU2015132212A (ru) 2017-03-15
CN111905104A (zh) 2020-11-10
CN105492004A (zh) 2016-04-13
CA2900372A1 (en) 2014-08-14
RU2675360C2 (ru) 2018-12-19
KR20150119007A (ko) 2015-10-23
US9943500B2 (en) 2018-04-17
EP2953623A4 (en) 2016-08-10
AU2014214547B2 (en) 2018-08-30
CA2900372C (en) 2021-06-08
US20160000748A1 (en) 2016-01-07
EP2953623A1 (en) 2015-12-16
WO2014121342A9 (en) 2016-09-09
JP2016507532A (ja) 2016-03-10
MX2015010190A (es) 2016-08-03

Similar Documents

Publication Publication Date Title
HK1216389A1 (zh) 治療局部微生物感染的方法
HK1225649A1 (zh) 用於治療細菌性感染的化合物和方法
EP2991638A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS
EP2991968A4 (en) Compounds and methods of treating infections
HUE044589T2 (hu) Gombaellenes helyi készítmény és kezelési eljárások
EP2953624A4 (en) METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS
HK1218293A1 (zh) 治療細菌感染的化合物和方法
EP2975649A4 (en) FIELD EFFECT TRANSISTOR
HK1213268A1 (zh) 用於治療細菌感染的甘露糖衍生物
ZA201503474B (en) Compositions and methods for treating bacterial infections
EP3019170A4 (en) Topical treatment of localized scleroderma
EP2969003A4 (en) METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS
EP3074038A4 (en) Method of treating nephropathy
EP2961401A4 (en) METHOD FOR TREATING OTOTOXICITY
EP3082860A4 (en) Method of treating wounds
ES2445491B1 (es) Método para prevenir y/o controlar infecciones bacterianas
AU2013901517A0 (en) Methods of Treating Bacterial Infections
AU2013901516A0 (en) Compounds and Methods of Treating Infections
AU2013900412A0 (en) Methods Of Treating Microbial Infections, Including Skin Infections
AU2013900411A0 (en) Methods Of Treating Microbial Infections, Including Mastitis
AU2013901359A0 (en) Methods of Treatment
AU2013904595A0 (en) Method of treating nephropathy
AU2013904712A0 (en) Method of Treatment
AU2013904170A0 (en) Method of treatment
AU2013904966A0 (en) Method of treating wounds